Van Vo

Van Vo

Auto-generated profile, based on publicly available information

Van Vo

Laboratory of Neurogenetics and Precision Medicine, Center for Water Intelligence and Community Health, College of Sciences, University of Nevada Las Vegas, Las Vegas, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
XZXiaowei Zhuang
Xiaowei Zhuang
VVVan Vo
Van Vo
MMMichael A. Moshi
Michael A. Moshi
KDKetan Dhede
Ketan Dhede
NGNabih Ghani
Nabih Ghani
EOEdwin C. Oh
Edwin C. Oh
Genome sequencing from wastewater enables accurate and cost-effective identification of SARS-CoV-2 variants. However, existing computational pipelines have limitations in detecting emerging variants not yet characterized in humans. Here, we present an unsupervised learning approach that clusters co-varying and time-evolving mutation patterns to identify SARS-CoV-2 variants. To build our model, we sequence 3659 wastewater samples collected over two years from urban and rural locations in Southern Nevada. We then develop a multivariate independent component analysis (ICA)-based pipeline to transform mutation frequencies into independent sources. These data-driven time-evolving and co-varying sources are compared to 8810 SARS-CoV-2 clinical genomes from Nevadans. Our method accurately detects the Delta variant in late 2021, Omicron variants in 2022, and emerging recombinant XBB variants in 2023. Our approach also reveals the spatial and temporal dynamics of variants in both urban and rural regions; achieves earlier detection of most variants compared to other computational tools; and uncovers unique co-varying mutation patterns not associated with any known variant. The multivariate nature of our pipeline boosts statistical power and supports accurate early detection of SARS-CoV-2 variants. This feature offers a unique opportunity to detect emerging variants and pathogens, even in the absence of clinical testing.

5 March 2025 in IJID Regions
Verified
Journal Article
Open access
CBCasey A. Barber
Casey A. Barber
CCChing-Lan Chang
Ching-Lan Chang
MMMichael A. Moshi
Michael A. Moshi
SAShahraiz Akbar
Shahraiz Akbar
VVVan Vo
Van Vo
DGDaniel Gerrity
Daniel Gerrity
This study explored expanded traveler- and tourism-focused wastewater monitoring in Las Vegas, Nevada, USA to complement community SARS-CoV-2 surveillance. Wastewater samples were collected November 2023 to July 2024 from the largest community-scale wastewater treatment plant in Southern Nevada, USA (N = 112 samples) and two upstream utility access holes (i.e. manholes), isolating an international airport (N = 68 samples) and a commercial area with high-density bars and nightclubs (N = 30-33 samples). Polymerase chain reaction-based methods quantified RNA concentrations of SARS-CoV-2 and pepper mild mottle virus; whole genome sequencing characterized SARS-CoV-2 variants (N = 83 qualifying samples). SARS-CoV-2 concentrations exhibited concordance between liquids- and solids-based approaches. Similar trends were observed between methods and sampling locations; however, select manhole-level findings suggested potentially divergent COVID-19 infection profiles relative to residents. Whole genome sequencing also demonstrated similarities across sampling locations, although airport samples facilitated the identification of SARS-CoV-2 variants that either failed to spread locally (EG.6, JN.1.11) or preceded detection at the wastewater treatment plant (JN.1.7, KP.3). These findings offer new insight into the operationalization of broader traveler- and tourism-focused wastewater monitoring, which may capture SARS-CoV-2 concentration spikes and genomic profiles in high-tourism/nightlife areas that community-scale sampling might otherwise miss.

25 March 2024 in eneuro
Verified
Journal Article
Open access
PDF file
NGNabih Ghani
Nabih Ghani
HBHayley Baker
Hayley Baker
AHAudrey Huntsinger
Audrey Huntsinger
TCTiffany Chen
Tiffany Chen
TFTiffany D. Familara
Tiffany D. Familara
EOEdwin C. Oh
Edwin C. Oh
Laboratory outreach programs for K-12 students in the United States from 2020 to 2022 were suspended or delayed due to COVID-19 restrictions. While Southern Nevada also observed similar closures for onsite programs, we and others hypothesized that in-person laboratory activities could be prioritized after increasing vaccine doses were available to the public and masking was encouraged. Here, we describe how the Laboratory of Neurogenetics and Precision Medicine at the University of Nevada Las Vegas (UNLV) collaborated with administrators from a local school district to conduct training activities for high school students during the COVID-19 pandemic. The Science Education for the Youth (SEFTY) program's curriculum was constructed to incorporate experiential learning, fostering collaboration and peer-to-peer knowledge exchange. Leveraging neuroscience tools from our UNLV laboratory, we engaged with 117 high school applicants from 2021 to 2022. Our recruitment efforts yielded a diverse cohort, with >41% Pacific Islander and Asian students, >9% African American students, and >12% multiracial students. We assessed the impact of the SEFTY program through pre- and postassessment student evaluations, revealing a significant improvement of 20.3% in science proficiency (p < 0.001) after participating in the program. Collectively, our laboratory curriculum offers valuable insights into the capacity of an outreach program to actively foster diversity and cultivate opportunities for academic excellence, even in the challenging context of a global pandemic.

29 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
CCChing-Lan Chang
Ching-Lan Chang
MMMichael A. Moshi
Michael A. Moshi
QNQuang-Huy Nguyen
Quang-Huy Nguyen
JOJunghun Oh
Junghun Oh
HNHa Nguyen
Ha Nguyen
EOEdwin C. Oh
Edwin C. Oh
The rapid evolution of antifungal resistance in Candida auris presents significant challenges for conventional public health surveillance methods, particularly in detecting emergent and highly transmissible drug-resistant variants. Using wastewater-based epidemiology (WBE) tools initially developed during the COVID-19 pandemic, we implemented a high-resolution facility-level early warning system to monitor C. auris infections and resistance patterns. Our comprehensive evaluation across Southern Nevada demonstrated that upstream sewage monitoring at healthcare facilities provided significant sensitivity (p90% genomic concordance between 443 wastewater-derived genomes and 2,977 clinical isolates. We also detected novel subclades and resistance mutations, including FKS1 Phe635Leu and co-occurring ERG11 / FKS1 variants in wastewater samples up to nearly five months before their appearance in clinical settings. Further transcriptomic profiling of drug-resistant isolates under antifungal and stress conditions identified previously uncharacterized adaptation mechanisms, including differential regulation of ribosomal assembly pathways and cell cycle checkpoints. These findings highlight how wastewater intelligence can substantially enhance traditional public health surveillance approaches for the early and proactive detection and monitoring of C. auris outbreaks and antifungal resistance.

18 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
CCChing-Lan Chang
Ching-Lan Chang
MMMichael A. Moshi
Michael A. Moshi
QNQuang-Huy Nguyen
Quang-Huy Nguyen
JOJunghun Oh
Junghun Oh
HNHa Nguyen
Ha Nguyen
EOEdwin C. Oh
Edwin C. Oh
The rapid evolution of antifungal resistance in Candidozyma auris (formerly Candida auris) presents significant challenges for conventional public health surveillance methods, particularly in detecting emergent and highly transmissible drug-resistant variants. Here, using wastewater-based epidemiology tools initially developed during the COVID-19 pandemic, we implement a high-resolution, facility-level early warning system to monitor C. auris infections and resistance patterns. Our evaluation across Southern Nevada demonstrates that upstream sewage monitoring at healthcare facilities provides significant sensitivity (p < 0.001) compared to wastewater treatment plant sampling. By combining amplicon sequencing and MALDI-TOF mass spectrometry, we identify clinically-relevant, resistance-associated variants in wastewater samples, while whole-genome sequencing reveals >90% genomic concordance between 443 wastewater-derived genomes and 2945 clinical isolates. We also detect previously unreported subclades and resistance mutations, including FKS1 Phe635Leu and co-occurring ERG11/FKS1 variants in wastewater samples up to nearly five months before their appearance in clinical settings. Transcriptomic profiling of drug-resistant isolates under antifungal and stress conditions identifies previously uncharacterized adaptation mechanisms, including differential regulation of ribosomal assembly pathways and cell cycle checkpoints. These findings highlight how wastewater intelligence can enhance traditional public health approaches for early detection and monitoring of C. auris outbreaks and antifungal resistance.